A Global Technology Company Dedicated to Affordable Medicine
Phylloceuticals uses a plant-made technology which offers lower overall investment and a much quicker response time for drug development. Phylloceuticals will enable drug development and manufacturing to happen fast (PhAAST™), achieving our goal to empower underserved areas of the world by providing access to the medicines that other areas of the world take for granted. Phylloceuticals is not a CDMO. We are not a biologics or pharma company. With our Plant-Made Pharmaceutical platform, our mission is to nucleate, enable, and help construct companies in these traditionally underserved regions and markets that lack capacity to manufacture biologics with our plant-made technology. We call it PhAAST™ - Pharmaceuticals as a Service Technology.
Phylloceuticals partners are a rare group of individuals and companies who came
together in 2020 with a grand idea - use their decades of experience to help get medicine to underserved areas of the world and underserved biologics markets. This team provides deep sector expertise in all facets of plants, biologics development, investment know-how, and project & product launch.
The Phylloceuticals Executive Team has worked together on multiple, and award winning projects, over their decades of contribution to biologics industry. This deeply shared history delivers intuitive and experienced solutions for Phylloceuticals clients and led to the formation of the PhAAST™ Platform.
This is the Phylloceuticals team. The team has been working on projects together for decades, and now are coming together to provide the PhAAST™ platform to clients around the globe.
From early stage funding, drug discovery and development, regulatory strategy, to engineering and construction, the ‘dream team’ at Phylloceuticals is sought out globally for their unique blend of expertise. [READ MORE]
Sign up to receive updates, news, and more.